SCHEMBL218170

SCHEMBL218170

CC(C)(C)CCC(=O)OO

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.33
GAA P10253 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MIF P14174 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trichloroethylene SCHEMBL12472316 0.85 TSHR (0.31) TSHR
SCHEMBL9559121 0.85 TSHR (0.39) TSHR
SCHEMBL6568397 0.83 TSHR (0.37) TSHRGAAALDH1A1
SCHEMBL10317424 0.81 MIF (0.31) MIF
SCHEMBL4809715 0.81 DGKA (0.38) TSHRGAAALDH1A1
SCHEMBL28565177 0.81 DGKA (0.38) TSHRGAAALDH1A1
SCHEMBL9364219 0.81 DGKA (0.38) TSHRGAAALDH1A1
SCHEMBL56700 0.81 DGKA (0.38) TSHRGAAALDH1A1
SCHEMBL245112 0.81 ALDH1A1 (0.50) TSHRGAAALDH1A1
SCHEMBL3019982 0.80 TSHR (0.31) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 957 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240206461-A1 DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS ENCAPSYS, LLC (US) 2024-06-27 US claimed
US-20240191022-A1 COMPOSITION COMPRISING AT LEAST ONE AROMATIC PEROXIDE AND AT LEAST ONE COMPOUND HAVING AN ETHER GROUP ARKEMA FRANCE (FR) 2024-06-13 US claimed
US-20240182680-A1 COMPOSITION COMPRISING AT LEAST ONE AROMATIC PEROXIDE AND AT LEAST ONE KETONE PEROXIDE ARKEMA FRANCE (FR) 2024-06-06 US claimed
US-20240182605-A1 COMPOSITION COMPRISING AT LEAST ONE AROMATIC PEROXIDE AND AT LEAST HYDROGEN PEROXIDE ARKEMA FRANCE (FR) 2024-06-06 US claimed
EP-4369931-A2 DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS Encapsys, LLC (US) 2024-05-22 EP claimed
EP-4370644-A1 CONSUMER PRODUCTS COMPRISING DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS The Procter & Gamble Company (US) 2024-05-22 EP claimed
EP-4355472-A1 DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS Encapsys, LLC (US) 2024-04-24 EP claimed
EP-4355848-A1 CONSUMER PRODUCTS COMPRISING DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS The Procter & Gamble Company (US) 2024-04-24 EP claimed
US-20240122176-A1 DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS ENCAPSYS, LLC (US) 2024-04-18 US claimed
US-20240101724-A1 ARTICLES COMPRISING CROSSLINKED POLYMER NETWORK COMPRISING THIOETHER CROSSLINKS AND PROCESS OF MAKING AND USING SAME THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE 2024-03-28 US claimed
WO-2001014459-A1 RADICAL-CURABLE ADHESIVE COMPOSITIONS, REACTION PRODUCTS OF WHICH DEMONSTRATE SUPERIOR RESISTANCE TO THERMAL DEGRADATION LOCTITE CORPORATION (US) 2001-03-01 WO claimed
US-6180040-B1 BLEND OF RESILIENCE POLYMER, FREE RADICAL INITIATOR AND CROSSLINKING AGENT ACUSHNET COMPANY 2001-01-30 US claimed
US-6150479-A CURABLE ADHESIVES FOR HEAT RESISTANCE LOCTITE CORPORATION (US) 2000-11-21 US claimed
EP-0950082-A4 REDUCING VOID FORMATION IN CURABLE ADHESIVE FORMULATIONS QUANTUM MATERIALS INC (US) 2000-07-12 EP claimed
WO-2000031149-A1 RADICAL-CURABLE ADHESIVE COMPOSITIONS, REACTION PRODUCTS OF WHICH DEMONSTRATE SUPERIOR RESISTANCE TO THERMAL DEGRADATION LOCTITE CORPORATION (US) 2000-06-02 WO claimed
WO-2000031165-A1 RADICAL-CURABLE ADHESIVE COMPOSITIONS, REACTION PRODUCTS OF WHICH DEMONSTRATE SUPERIOR RESISTANCE TO THERMAL DEGRADATION LOCTITE CORPORATION (US) 2000-06-02 WO claimed
WO-2000012281-A1 METHOD OF FORMING A GOLF BALL CORE ACUSHNET COMPANY (US) 2000-03-09 WO claimed
EP-0950082-A1 REDUCING VOID FORMATION IN CURABLE ADHESIVE FORMULATIONS QUANTUM MATERIALS, INC. (US) 1999-10-20 EP claimed
WO-1998030647-A1 REDUCING VOID FORMATION IN CURABLE ADHESIVE FORMULATIONS QUANTUM MATERIALS, INC. (US) 1998-07-16 WO claimed
EP-0355997-B1 POLYMERISATION PROCESS AND CATALYST SYSTEM THEREFOR POLYSAR LIMITED (CA) 1993-09-15 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240206461-A1 DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS CETP, CHMP4B, HDLBP TSHR 4722/4885GAA 1691/4885ALDH1A1 193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.